TickerFacts.

Turn Therapeutics Inc. (TTRX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$52.7K
Year ended 2025-12-31
2024-12-31: $47.5K2025-12-31: $52.7K$52.7K
2024-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$52.7K+11.1%2026-03-31, From 2025-01-01
2024-12-31$47.5Kn/a2026-03-31, From 2024-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Turn Therapeutics Inc. (TTRX)2025-12-31$52.7K+11.1%
Imunon, Inc. (IMNN)2024-12-31$240.0K-3.2%
PMGC Holdings Inc. (ELAB)2025-12-31$96.1Kn/m
NewcelX Ltd. (NCEL)2025-12-31$55.0K-86.7%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$70.0Kn/m
Decoy Therapeutics Inc. (DCOY)2025-12-31$7.2K+61.6%
Lantern Pharma Inc. (LTRN)2025-12-31$17.3K0.0%
Edesa Biotech, Inc. (EDSA)2025-09-30$119.3K-35.9%
Traws Pharma, Inc. (TRAW)2025-12-31$61.0K+408.3%

Compare TTRX, IMNN, ELAB, NCEL side by side · Screen every company in Pharmaceutical Preparations ↗